Hep C Can Be Eliminated by 2030, Worldwide

News
Slideshow

A new study models the impact of 4 key public health interventions on global HCV burden to see if WHO elimination targets are realistic.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill

Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill

Sydney Jennings
July 17th 2025
Article

Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Sydney Jennings
May 7th 2025
Podcast

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies / Image credit: ©Ezume Images/AdobeStock

New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies

Sydney Jennings
July 8th 2025
Article

New findings showcase the transformative impact of long-acting injectable therapies for effective HIV treatment and prevention.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Image courtesy of Cincinnati Children's

Intranasal COVID-19 Vaccine Found Safe and Immunogenic in Open Label Phase 1 Clinical Trial

Grace Halsey
July 7th 2025
Article

Among recipients of high-dose CVXGA, relative vaccine effectiveness was 67.8% against symptomatic COVID infection at a median 7.3 months post-vaccination.

Majority of Americans (8 in 10) Support Routine Childhood Vaccine Requirements, According to New Harvard Poll / image credit ©Sula Nualpradid/stock.adobe.com

Majority of Americans (8 in 10) Support Routine Childhood Vaccine Requirements, According to New Harvard Poll

Grace Halsey
July 1st 2025
Article

As authorities record data on the largest US measles outbreak in decades, 79% of Americans support school vaccine mandates for children, an encouraging result.

© 2025 MJH Life Sciences

All rights reserved.